ONSURA - Trademark Details
Status: 734 - Fifth Extension - Granted
Image for trademark with serial number 87641241
Serial Number
87641241
Word Mark
ONSURA
Status
734 - Fifth Extension - Granted
Status Date
2021-08-09
Filing Date
2017-10-11
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-12-25
Attorney Name
Laurence Rickles
Law Office Assigned Location Code
L40
Employee Name
MARTIN, CHRISTINE C
Statements
Goods and Services
Pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of depression; pharmaceutical preparations for the prevention and treatment of psychological disorders; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of osteoporosis; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; pharmaceutical preparations for the prevention and treatment of aids-related disorders; pharmaceutical preparations that support, encourage and promote bone strength; pharmaceutical preparations that support, encourage and promote bone health; pharmaceutical preparations used in the treatment of bone disorders and bone diseases; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, fertility enhancement preparations; pharmaceutical preparations, namely, hormone replacement therapy preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, pharmaceutical agents affecting the central nervous system; pharmaceutical preparations, namely, pharmaceutical agents affecting circulatory systems; pharmaceutical preparations, namely, pharmaceutical agents affecting sensory organs; pharmaceutical preparations, namely, pharmaceutical agents affecting urogenital organs; pharmaceutical preparations, namely, pharmaceutical agents affecting peripheral nervous system
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-10-18
Primary Code
005
Current Trademark Owners
Party Name
Teva Pharmaceuticals USA, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Teva Pharmaceuticals USA, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Teva Pharmaceuticals USA, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Laurence Rickles
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2017-10-14NEW APPLICATION ENTERED IN TRAM
2017-10-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-01-10ASSIGNED TO EXAMINER
2018-01-16NON-FINAL ACTION WRITTEN
2018-01-16NON-FINAL ACTION E-MAILED
2018-01-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-07-11TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-07-11CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-07-12TEAS/EMAIL CORRESPONDENCE ENTERED
2018-08-07SUSPENSION LETTER WRITTEN
2018-08-07LETTER OF SUSPENSION E-MAILED
2018-08-07NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2018-10-26TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2018-11-06ASSIGNED TO LIE
2018-11-13CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-11-13TEAS/EMAIL CORRESPONDENCE ENTERED
2018-11-16APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-05NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-12-25PUBLISHED FOR OPPOSITION
2018-12-25OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-02-19NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-08-13TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-08-13ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-08-14TEAS EXTENSION RECEIVED
2019-08-14EXTENSION 1 FILED
2019-08-14EXTENSION 1 GRANTED
2019-08-16NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-02-19TEAS EXTENSION RECEIVED
2020-02-19EXTENSION 2 FILED
2020-02-19EXTENSION 2 GRANTED
2020-02-29NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-13TEAS EXTENSION RECEIVED
2020-08-13EXTENSION 3 FILED
2020-08-13EXTENSION 3 GRANTED
2020-08-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-11TEAS EXTENSION RECEIVED
2021-02-11EXTENSION 4 FILED
2021-02-11EXTENSION 4 GRANTED
2021-02-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-08-04TEAS EXTENSION RECEIVED
2021-08-09CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-08-04EXTENSION 5 FILED
2021-08-09EXTENSION 5 GRANTED
2021-08-10NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED